1. Metastatic Colorectal Cancer: Management With Trifluridine/Tipiracil
   Teresa White et al, 2017, Clinical Journal of Oncology Nursing CrossRef
2. Further Therapeutic Options in Heavily Pretreated Colorectal Cancer Patients
   Aneta L. Zygulska, 2019, Multidisciplinary Approach for Colorectal Cancer CrossRef
3. Difference in Neutropenia due to Administration Schedule of TAS-102
   Yoichiro Yoshida et al, 2017, Case Reports in Oncology CrossRef
4. TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
   Cheng-Jiang Liu et al, 2021, Gastroenterology Research and Practice CrossRef
5. Comparison of the efficacy and safety of third-line treatments for metastatic colorectal cancer: a systematic review and network meta-analysis
   Loulu Gao et al, 2023, Frontiers in Oncology CrossRef
6. Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
   Yoshiaki Fujimoto et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
7. A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)
   Yoichiro Yoshida et al, 2019, Journal of the Anus, Rectum and Colon CrossRef